CONNECT WITH A CEM
“I find it comforting to know a local CEM is available to help with questions I may have about my treatment, like questions about insurance coverage.”
- Member of the Hemophilia A Community
“I find it comforting to know a local CEM is available to help with questions I may have about my treatment, like questions about insurance coverage.”
- Member of the Hemophilia A Community
The EDGE is Genentech's biannual newsletter for the hemophilia community. Each issue of The EDGE offers a look into unique aspects of the community, along with individual stories from all walks of life.
Download the latest edition now
Listen in on a conversation between generations of men who are managing their hemophilia
See how we’re working to provide medicine for those in need, no matter where they may live
Hear how our team of Hemophilia Community Clinical Education Managers provides support, in their own words.
Monitoring the safety of a drug during clinical trials AND after is called pharmacovigilance. “Pharma” comes from the Greek word “pharmakeia”—for drugs, medicines, or remedies. “Vigilance” is from the Latin “vigilantia,” meaning wakefulness, watchfulness, or attention.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.